Estudio de patrones de metilación génica en tumores del tubo digestivo

Background: The loss of tumor suppresor gene function damages the defensive mechanisms that protect the indemnity of genetic material. Promoter gene methylation is one of the inactivation mechanisms of suppressor genes. Aim: To study the methylation pattern of a group of genes in biopsy samples of g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roa S,Juan Carlos, García M,Patricia, Melo A,Angélica, Tapia E,Oscar, Villaseca H,Miguel, Araya O,Juan Carlos, Guzmán G,Pablo
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2008
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000400005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872008000400005
record_format dspace
spelling oai:scielo:S0034-988720080004000052008-06-16Estudio de patrones de metilación génica en tumores del tubo digestivoRoa S,Juan CarlosGarcía M,PatriciaMelo A,AngélicaTapia E,OscarVillaseca H,MiguelAraya O,Juan CarlosGuzmán G,Pablo Digestive system neoplasms Genes, supressor Methylation Background: The loss of tumor suppresor gene function damages the defensive mechanisms that protect the indemnity of genetic material. Promoter gene methylation is one of the inactivation mechanisms of suppressor genes. Aim: To study the methylation pattern of a group of genes in biopsy samples of gastrointestinal tumors. Material and methods: Forty eight gastric, 25 gallbladder, 24 colon and 6 pancreas cancer biopsy samples were randomly selected. The methylation pattern of CDH1, FHIT, CDKN2A, APC and MLH1 genes, was studied using a specific polymerase chain reaction test for methylation. Demographic, morphological and follow up variables of patients bearing the tumors were also analyzed. Results: The general methylation frequency of CDH1, FHIT, CDKN2A, APC and MLH1 genes was 64.1, 56, 39.8, 18.1 and 34% respectively. In gastric cancer samples there was a correlation between APC gene methylation and well differentiated tumors; between CDH1 methylation and Lauren diffuse type and the presence of three or more metastasic lymph nodes; between FHIT, CDKN2A and CDH1 gene methylation and male gender. In ¡ess differentiated gallbladder tumors, the frequency of CDH1 methylation was higher. There was a tendency towards a lower survival in colon and gastric cancer when MLH1 (p =0.07) y CDKN2A (p= 0.06) were methylated, respectively. Conclusions: An abnormal methylation pattern was associated with morphological features in gastric and gallbladder cancer and with a tendency towards a lower survival in colon and gastric cancerinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.4 20082008-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000400005es10.4067/S0034-98872008000400005
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Digestive system neoplasms
Genes, supressor
Methylation
spellingShingle Digestive system neoplasms
Genes, supressor
Methylation
Roa S,Juan Carlos
García M,Patricia
Melo A,Angélica
Tapia E,Oscar
Villaseca H,Miguel
Araya O,Juan Carlos
Guzmán G,Pablo
Estudio de patrones de metilación génica en tumores del tubo digestivo
description Background: The loss of tumor suppresor gene function damages the defensive mechanisms that protect the indemnity of genetic material. Promoter gene methylation is one of the inactivation mechanisms of suppressor genes. Aim: To study the methylation pattern of a group of genes in biopsy samples of gastrointestinal tumors. Material and methods: Forty eight gastric, 25 gallbladder, 24 colon and 6 pancreas cancer biopsy samples were randomly selected. The methylation pattern of CDH1, FHIT, CDKN2A, APC and MLH1 genes, was studied using a specific polymerase chain reaction test for methylation. Demographic, morphological and follow up variables of patients bearing the tumors were also analyzed. Results: The general methylation frequency of CDH1, FHIT, CDKN2A, APC and MLH1 genes was 64.1, 56, 39.8, 18.1 and 34% respectively. In gastric cancer samples there was a correlation between APC gene methylation and well differentiated tumors; between CDH1 methylation and Lauren diffuse type and the presence of three or more metastasic lymph nodes; between FHIT, CDKN2A and CDH1 gene methylation and male gender. In ¡ess differentiated gallbladder tumors, the frequency of CDH1 methylation was higher. There was a tendency towards a lower survival in colon and gastric cancer when MLH1 (p =0.07) y CDKN2A (p= 0.06) were methylated, respectively. Conclusions: An abnormal methylation pattern was associated with morphological features in gastric and gallbladder cancer and with a tendency towards a lower survival in colon and gastric cancer
author Roa S,Juan Carlos
García M,Patricia
Melo A,Angélica
Tapia E,Oscar
Villaseca H,Miguel
Araya O,Juan Carlos
Guzmán G,Pablo
author_facet Roa S,Juan Carlos
García M,Patricia
Melo A,Angélica
Tapia E,Oscar
Villaseca H,Miguel
Araya O,Juan Carlos
Guzmán G,Pablo
author_sort Roa S,Juan Carlos
title Estudio de patrones de metilación génica en tumores del tubo digestivo
title_short Estudio de patrones de metilación génica en tumores del tubo digestivo
title_full Estudio de patrones de metilación génica en tumores del tubo digestivo
title_fullStr Estudio de patrones de metilación génica en tumores del tubo digestivo
title_full_unstemmed Estudio de patrones de metilación génica en tumores del tubo digestivo
title_sort estudio de patrones de metilación génica en tumores del tubo digestivo
publisher Sociedad Médica de Santiago
publishDate 2008
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000400005
work_keys_str_mv AT roasjuancarlos estudiodepatronesdemetilaciongenicaentumoresdeltubodigestivo
AT garciampatricia estudiodepatronesdemetilaciongenicaentumoresdeltubodigestivo
AT meloaangelica estudiodepatronesdemetilaciongenicaentumoresdeltubodigestivo
AT tapiaeoscar estudiodepatronesdemetilaciongenicaentumoresdeltubodigestivo
AT villasecahmiguel estudiodepatronesdemetilaciongenicaentumoresdeltubodigestivo
AT arayaojuancarlos estudiodepatronesdemetilaciongenicaentumoresdeltubodigestivo
AT guzmangpablo estudiodepatronesdemetilaciongenicaentumoresdeltubodigestivo
_version_ 1718436372140785664